Structural and remodeling indices in the cancellous bone of the proximal femur across adulthood

Bone

Volumn 40, Issue 1, 2007, Pages 211-217

  Tsangari, Helen ^a   Findlay, David M ^b   Fazzalari, Nicola L ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Age; Modeling; Proximal femur; Remodeling; Trabecular bone

Indexed keywords

ADULT; ADULTHOOD; AGED; ARTICLE; AUTOPSY; BONE REMODELING; BONE STRUCTURE; BONE TURNOVER; CANCELLOUS BONE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; FEMUR; FEMUR FRACTURE; FRAGILITY FRACTURE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOLYSIS; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE REMODELING; CADAVER; FEMALE; FEMUR NECK; HUMANS; MALE; MIDDLE AGED;

EID: 33751509321     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.07.007     Document Type: Article

References (37)

1. Ballabriga A. Morphological and physiological changes during growth: an update. Eur. J. Clin. Nutr. 54 (2000) 1-6
2. Mosekilde L. Mechanisms of age-related bone loss. Novartis Found Symp. 235 (2001) 150-166
3. Parfitt A., Travers R., Rauch F., and Glorieux F.H. Structural and cellular changes during bone growth in healthy children. Bone 27 (2000) 487-494
4. Rizzoli R., Bonjour J.P., and Ferrari S.L. Osteoporosis, genetics and hormones. J. Mol. Endocrinol. 26 (2001) 79-94
5. Seeman E., and Eisman J.A. 7: Treatment of osteoporosis: why, whom, when and how to treat. Medical Journal of Australia 180 (2004) 298-303
6. Marcus R. An expanded overview of postmenopausal osteoporosis. J. Musculoskel. Neuron. Interact. 2 (2002) 195-197
7. Jarvinen T.L., Sievanen H., Jokihaara J., and Einhorn T. Revival of bone strength: the bottom line. J. Bone Miner. Res. 20 (2005) 717-720
8. Parfitt A. What is the normal rate of bone remodeling?. Bone 35 (2004) 1-3
9. Stone K., Seeley D., Lui L.-Y., Cauley J., Ensrud K., Browner W., et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J. Bone Miner. Res. 18 (2003) 1947-1954
10. Black D., Thompson D., Bauer D., Ensrud K., Musliner T., Hochberg M., et al. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial, FIT research group. J. Clin. Endocrinol. Metab. 85 (2000) 4118-4124
11. Cummings S.R., Nevitt M.C., Browner W.S., Stone K., Fox K.M., Ensrud K.E., et al. Risk factors for hip fracture in white women. Study of osteoporotic fractures research group. N. Engl. J. Med. 332 (1995) 767-773
12. Eastell R., Barton I., Hannon R., Chines A., Garnero P., and Delmas P. Relationship of early changes in bone resorption to the reduction in fracture risk with risendronate. J. Bone Miner. Res. 18 (2003) 1051-1056
13. Parfitt A. Skeletal heterogeneity and the purposes of bone remodeling. Osteoporosis (1996), Academic Press 315-329
14. Ahlborg H., Johnell O., Turner C., Rannevik G., and Karlsson M. Bone loss and bone size after menopause. N. Engl. J. Med. 349 (2003) 327-334
15. Heaney R., Barger-Lux M., Davies K., Ryan R., Johnson M., and Gong G. Bone dimensional change with age: interactions of genetic, hormonal, and body size variables. Osteoporos Int. 7 (1997) 426-431
16. Smith R., and Walker R. Femoral expansion in aging women: implications for osteoporosis and fractures. Science 145 (1964) 156-157
17. Epker B., and Frost H. Periosteal appositional bone growth from age two to age seventy in man. Anat. Rec. 154 (1966) 573-578
18. Power J., Loveridge N., Rushton N., Parker M., and Reeve J. Evidence for bone formation on the external "periosteal" surface of the femoral neck: a comparison of intracapsular hip fracture cases and controls. Osteoporos Int. 14 (2003) 141-145
19. Lazenby R. Continuing periosteal apposition: II. The significance of peak bone mass, strain equilibrium, and age-related activity differentials for mechanical compensation in human tubular bones. Am. J. Phys. Anthropol. 82 (1990) 473-484
20. Kobayashi S., Takahashi H., Ito A., Saito N., Nawata M., Horiuchi H., et al. Trabecular minimodeling in human iliac bone. Bone 32 (2003) 163-169
21. Lindsay R., Cosman F., Zhou H., Bostrom M., Shen V., Cruz J.D., et al. A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide. J. Bone Miner. Res. 21 (2006) 366-373
22. Amling M., Posl M., Ritzel H., Hahn M., Vogel M., Wening V., et al. Architecture and distribution of cancellous bone yield vertebral fracture clues. Arch. Orthop. Trauma Surg. 115 (1996) 262-269
23. Parfitt A.M., Mathews C.H.E., Villanueva A.R., Kleerekoper M., Frame B., and Rao D.S. Relationships between surface, volume, and thickness of iliac trabecular bone in ageing and in osteoporosis: implications for the microanatomic and cellular mechanisms of bone loss. J. Clin. Invest. 72 (1983) 1396-1409 [October]
24. Parkinson I.H., and Fazzalari N.L. Interrelationships between structural parameters of cancellous bone reveal accelerated structural change at low bone volume. J. Bone Miner. Res. 18 (2003) 2200-2205
25. Moore R.J., Durbridge T.C., McNeil P.J., Parkinson I.H., Need A.G., and Vernon-Roberts B. Trabecular spacing in post-menopausal Australian women with and without vertebral fractures. Aust. N.Z. J. Med. 22 (1992) 269-273
26. Faccini J., Exton-Smith A., and Boyde A. Disorders of bone and fracture of the femoral neck. Lancet 7969 (1976) 1089-1092
27. Fazzalari N.L., Kuliwaba J.S., Atkins G.J., Forwood M.R., and Findlay D.M. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J. Bone Miner. Res. 16 (2001) 1015-1027
28. Fazzalari N.L., Darracott J., and Vernon-Roberts B. A quantitative description of selected stress regions of cancellous bone in the head of the femur using automatic image analysis. Metab. Bone Dis. Relat. Res. 5 (1983) 119-125
29. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 359 (2002) 1841-1850
30. Chavassieux P., and Meunier P. Histomorphometric approach of bone loss in men. Calcif. Tissue Int. 69 (2001) 209-213
31. Compston J., Mellish R., Croucher P., Newcombe R., and Garrahan N. Structural mechanisms of trabecular bone loss in man. Bone Miner. 6 (1989) 339-350
32. Burger H., Dudley E., Hopper J., Groome N., Guthrie J.R., Green A., et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibitins during the menopausal transition in a population-based cohort of women. J. Clin. Endocrinol. Metab. 84 (1999) 4025-4030
33. Tsangari H., Findlay D.M., Kuliwaba J.S., Atkins G.J., and Fazzalari N.L. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 35 (2004) 334-342
34. Weinstein R., and Manolagas S. Apoptosis and osteoporosis. Am. J. Med. 108 (2000) 153-164
35. Parfitt A. Implications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 13 (1992) S41-S42
36. Felsenberg D., and Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin. Ther. 27 (2005) 1-11
37. Carrington J. Aging bone and cartilage: cross-cutting issues. Biochem. Phys. Res. Commun. 328 (2005) 700-708